0000884905-18-000077.txt : 20181101 0000884905-18-000077.hdr.sgml : 20181101 20181101170902 ACCESSION NUMBER: 0000884905-18-000077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181031 FILED AS OF DATE: 20181101 DATE AS OF CHANGE: 20181101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roby Anne K CENTRAL INDEX KEY: 0001595290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11037 FILM NUMBER: 181154701 MAIL ADDRESS: STREET 1: 39 OLD RIDGEBURY ROAD CITY: DANBURY STATE: CT ZIP: 06810-5113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRAXAIR INC CENTRAL INDEX KEY: 0000884905 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INORGANIC CHEMICALS [2810] IRS NUMBER: 061249050 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 RIVERVIEW DRIVE CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 2038372000 MAIL ADDRESS: STREET 1: 10 RIVERVIEW DRIVE CITY: DANBURY STATE: CT ZIP: 06810 FORMER COMPANY: FORMER CONFORMED NAME: UNION CARBIDE INDUSTRIAL GASES INC DATE OF NAME CHANGE: 19600201 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-10-31 1 0000884905 PRAXAIR INC PX 0001595290 Roby Anne K C/O PRAXAIR, INC. 10 RIVERVIEW DRIVE DANBURY CT 06810 0 1 0 0 Senior Vice President Common Stock 2018-10-31 4 D 0 1328.5434 0 D 0 I 401(k) Common Stock 2018-10-31 4 D 0 26747.951 0 D 0 D Restricted Stock Units 0 2018-10-31 4 D 0 3885 0 D Common Stock 3885 0 D Restricted Stock Units 0 2018-10-31 4 D 0 3510 0 D Common Stock 3510 0 D Restricted Stock Units 0 2018-10-31 4 D 0 4328 0 D Common Stock 4328 0 D Restricted Stock Units 0 2018-10-31 4 D 0 3588 0 D Common Stock 3588 0 D Restricted Stock Units 0 2018-10-31 4 D 0 2960 0 D Common Stock 2960 0 D Stock Option (right to buy) 97.84 2018-10-31 4 D 0 13195 D 2021-02-22 Common Stock 13195 0 D Stock Option (right to buy) 109.68 2018-10-31 4 D 0 18430 D 2022-02-28 Common Stock 18430 0 D Stock Option (right to buy) 110.58 2018-10-31 4 D 0 15790 D 2023-02-26 Common Stock 15790 0 D Stock Option (right to buy) 128.80 2018-10-31 4 D 0 19900 D 2024-02-25 Common Stock 19900 0 D Stock Option (right to buy) 128.38 2018-10-31 4 D 0 26490 D 2025-02-24 Common Stock 26490 0 D Stock Option (right to buy) 102.22 2018-10-31 4 D 0 49405 D 2026-02-23 Common Stock 49405 0 D Stock Option (right to buy) 118.71 2018-10-31 4 D 0 39585 D 2027-02-28 Common Stock 39585 0 D Stock Option (right to buy) 154.00 2018-10-31 4 D 0 32335 D 2028-02-27 Common Stock 32335 0 D Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Anthony M. Pepper, Attorney-in-Fact 2018-11-01